VAERS reports by lot

Pfizer COVID-19 lot EKS730: VAERS reports

43 VAERS reports list lot EKS730 as a Pfizer COVID-19 vaccine, received between 2020-12-18 and 2024-01-09. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
43
Reports
12%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5326%
Neurological4020%
Gastrointestinal2412%
Cardiac / Cardiovascular2110%
Musculoskeletal2010%
Dermatological (non-injection-site)147%
Respiratory126%
Injection-site / Local reaction126%
Allergic / Anaphylactic42%
Psychiatric / Neuropsychiatric42%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
New York5
California3
Massachusetts3
Texas3
Pennsylvania3
Oklahoma2
Michigan2
New Jersey2
Illinois2
North Carolina2
New Mexico2
Alaska1

Reports by month received

MonthReportsBar
2020-1216
2021-0116
2021-023
2021-032
2021-041
2021-071
2021-111
2021-122
2024-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Pfizer COVID-19 lots (A–Z): EK5730 · EK9231 · EK9321 · EL0140 · EL0142 · EL1283

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.